Literature DB >> 16767286

The broad homeostatic role of natriuretic peptides.

Thomas Maack1.   

Abstract

A brief non-inclusive review on natriuretic peptides (NP), their receptors, and their main functional properties is presented. The three main NP, atrial (ANP), brain (BNP) and C-type (CNP) are considered. Guanylyl cyclase receptors modulate all the known systemic effects of NP. Clearance receptors determine the metabolic disposal of NP and in this manner regulate their plasma levels and/or local tissue concentrations. Structure-function properties, and homeostatic properties of NP receptors are presented. ANP, which plays a major role in pressure-volume homeostasis, is discussed in relationship to its effects on renal hemodynamic and excretory functions, inhibition of the renin-angiotensin-aldosterone system, vasorelaxant, and third-spacing action. For BNP special attention is directed to its role as a negative modulator of ventricular remodeling, in view of its anti-hypertrophic, anti-fibrotic and anti-inflammatory effects in the heart. The major effect of CNP in promoting vertebral and longitudinal bone growth is briefly addressed. Finally, emphasis is placed on the recent discovery that ANP affects fat metabolism in humans due to its powerful lipolytic action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767286     DOI: 10.1590/s0004-27302006000200006

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  11 in total

1.  Modulating effects of preconditioning exercise in the expression of ET-1 and BNP via HIF-1α in ischemically injured brain.

Authors:  Huijie Wang; Feng Niu; Wei Fan; Jimin Shi; Jihong Zhang; Bing Li
Journal:  Metab Brain Dis       Date:  2019-06-20       Impact factor: 3.584

2.  Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer.

Authors:  Eric D Pressly; Richard A Pierce; Luke A Connal; Craig J Hawker; Yongjian Liu
Journal:  Bioconjug Chem       Date:  2013-01-11       Impact factor: 4.774

3.  Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET.

Authors:  Yongjian Liu; Eric D Pressly; Dana R Abendschein; Craig J Hawker; Geoffrey E Woodard; Pamela K Woodard; Michael J Welch
Journal:  J Nucl Med       Date:  2011-11-02       Impact factor: 10.057

4.  Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography.

Authors:  Dolonchampa Maji; Metasebya Solomon; Annie Nguyen; Richard A Pierce; Pamela K Woodard; Walter J Akers; Samuel Achilefu; Joseph P Culver; Dana R Abendschein; Monica Shokeen
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

5.  Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET.

Authors:  Yongjian Liu; Dana Abendschein; Geoffrey E Woodard; Raffaella Rossin; Kyle McCommis; Jie Zheng; Michael J Welch; Pamela K Woodard
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

6.  Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.

Authors:  Anagha Sen; Prerna Kumar; Renu Garg; Sarah H Lindsey; Prasad V G Katakam; Meaghan Bloodworth; Kailash N Pandey
Journal:  FEBS J       Date:  2016-04-05       Impact factor: 5.542

Review 7.  B-type natriuretic peptide levels and benign adiposity in obese heart failure patients.

Authors:  Vasiliki Katsi; Maria Marketou; Alexios S Antonopoulos; Dimitrios Vrachatis; Fragkiskos Parthenakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

8.  A Clinical and Physiological Prospective Observational Study on the Management of Pediatric Shock in the Post-Fluid Expansion as Supportive Therapy Trial Era.

Authors:  Nchafatso G Obonyo; Peter Olupot-Olupot; Ayub Mpoya; Julius Nteziyaremye; Martin Chebet; Sophie Uyoga; Rita Muhindo; Jonathon P Fanning; Kenji Shiino; Jonathan Chan; John F Fraser; Kathryn Maitland
Journal:  Pediatr Crit Care Med       Date:  2022-04-21       Impact factor: 3.971

Review 9.  SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease.

Authors:  Geert Hendrikx; Stefan Vöö; Matthias Bauwens; Mark J Post; Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-12       Impact factor: 9.236

10.  MicroRNA-143 modulates the expression of Natriuretic Peptide Receptor 3 in cardiac cells.

Authors:  Juan Wang; Kai Sing Tong; Lee Lee Wong; Oi-Wah Liew; Divya Raghuram; Arthur Mark Richards; Yei-Tsung Chen
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.